Michael Zaleski, D.O.

Dr. Zaleski of Clinical Pathology Associates
Sub-Specialties
Surgical PathologyUrologic Pathology

Joined Clinical Pathology Associates:  2024

Board Certifications:

  • Anatomic and Clinical Pathology (2002)

Fellowships:

  • Surgical Pathology Fellow, MD Anderson Cancer Center
  • Genitourinary Pathology Fellow, MD Anderson Cancer Center

Residency:

  • Anatomic & Clinical Pathology Residency, Penn State Hershey Medical Center

Medical School:

  • Doctor of Osteopathic Medicine, Philadelphia College of Osteopathic Medicine

Undergraduate Education:

  • Business/Biology, Penn State University
  • B.S. in Biology/Biochemistry (Pre-medicine), University of Scranton

Additional Education:

  • Biochemistry, University of Scranton (Graduate)

Publications:

  • Zaleski M, Chen H, Roy-Chowdhuri S, Patel KP, Luthra R, Routbort MJ, Kamat AM, Gao J, SiefkerRadtke A, Czerniak B, Guo CC. Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma An Analysis of 30 Cases by Next-Generation Sequencing.
    American Journal of Clinical Pathology. 2022 Apr 25.
  • Oramas DM, Zaleski M, Moran CA. Sarcomatoid Mesothelioma: A Clinicopathological and Immunohistochemical Study of 64 Cases. Int J Surg Pathol. 2021 May 3.
  • Kwon DH, Malpica A, Zaleski M, Euscher ED, Ramalingam P. Immunohistochemical Loss of DPC4 in Tumors With Mucinous Differentiation Arising in or Involving the Gynecologic Tract. Int J Gynecol Pathol. 2021 Jan 5.
  • Zaleski M, Kalhor N, Moran CA. Typical and Atypical Carcinoid Tumors of the Mediastinum: A Biomarker Analysis of 27 Cases With Clinical Correlation. Int J Surg Pathol. 2020 Nov 27.
  • Zaleski M, Kalhor N, Moran CA. Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1. Pathol Res Pract. 2020 Nov 2;216(12):153267.
  • Zaleski M, Truong M, Moran CA. Primary mediastinal hondrosarcomas: do they really exist? Mediastinum 2020.
  • Zaleski M, Kalhor N, Moran CA. Mucous gland adenoma: The spectrum of growth patterns and the diagnostic challenges. Advances in Anatomic Pathology 2020 Sep 8.
  • Febres-Aldana C, Poppiti R, Varlotto J, Voland R, Zaleski M, Sharzehi S, Rassaei N. Diabetes Mellitus Type 2 Is Associated With Increased Tumor Expression Of Programmed Death-Ligand 1 (Pd-L1) In Surgically Resected Non-Small Cell Lung Cancer—A Matched Case-Control Study. Cancer Treatment and Research Communications. 2020 Mar 5: 100170.
  • Zhang D, Gonzalez RS, Feely M, Umrau K, Lee H, Allende DS, Karamchandani DM, Zaleski M, Lin J, Westerhoff M, Zhang X. Clinicopathologic features of Buschke-Löwenstein tumor: a multiinstitutional analysis of 38 cases. Virchows Archiv. 2020 Apr 15:1-8.
  • Mejbel HA, Nelson KC, Pradhan D, Ivan D, Zaleski M, Nagarajan P, Tetzlaff MT, Curry JL, Torres‐Cabala CA, Prieto VG, Aung PP. Cutaneous Neoplasms Composed of Melanoma and Carcinoma: a Rare but Important Diagnostic Pitfall and Review of the Literature. Journal of cutaneous pathology. 2020 Jan;47(1):36-46.
  • Buj R, Chen CW, Dahl ES, Leon KE, Kuskovsky R, Maglakelidze N, Navaratnarajah M, Zhang G, Doan MT, Jiang H, Zaleski M, et al. Suppression of p16 induces mTORC1-mediated nucleotide metabolic reprogramming. Cell reports. 2019 Aug 20; 28(8):1971-80.
  • Zaleski M, Aramin H, Prieto VG, Aung PP. Skin and superficial soft tissue neoplasms with multinucleated giant cells: Clinical, histologic, phenotypic, and molecular differentiating features. Annals of Diagnostic Pathology. 2019 Jul 2.
  • Amponsa VO, Shuman L, Ellis J, Wang E, Walter V, Owens RG, Zaleski M, Warrick JI, Raman JD, DeGraff DJ. Carcinogen-induced bladder cancer in the FVB mouse strain is associated with glandular differentiation and increased Cd274/Pdl-1 expression. American journal of clinical and experimental urology. 2019; 7 (3):139.
  • Chen YA, Karamchandani DM, Mack J, Zaleski M, Xu L, Dodge DG, Chetlen AL. Excision Recommended in High Risk Patients: Revisiting the Diagnosis of Papilloma on Core Biopsy in the Context of Patient Risk. Breast J. 2019, Jan 30.
  • Zaleski M, Gogoj A, Walter V, Raman J, Kaag M, Merrill S, Drabick J, Joshi M, Holder S, DeGraff D, Warrick J. Mitotic Activity in Non-invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to The Contemporary Two-Tier Grading System. Hum Pathol. 2018 Oct.
  • Zaleski M, Erdman P, Michael A, Adams J, Boesch R, Allison L, Hess W, Rudy A, Mailander P, Myers D, Craft D. Establishing a Long-term Model For Analysis and Improvement of Blood Culture Fill Volumes. Am J Clin Pathol. 2018, Sep 26.
  • Zaleski M, Chen YA, Chetlen AL, Mack J, Xu L, Dodge DG, Karamchandani DM. Should we excise? Are there any clinical or histologic features that predict upgrade in papillomas, incidental or nonincidental? Ann Diagn Pathol. 2018 May 11; 35: 62-68.
  • Zaleski, M, Chu Y, Frauenhoffer E, Malysz J, Rassaei N, Abendroth C, Millington K. A case of vasculopathy of unknown etiology associated with fatal hydrops fetalis and review of the literature on intimomedial mucoid degeneration. Cardiovascular Pathology. Mar 1 2018.33; 6:
    39-44.
  • Zaleski M, Ferringer T. Extramammary Paget’s Disease, Cutis. 2015 June; 95(6):308, 315-316